Livac is actively seeking AUD $6m to support US market entry
Article by Louise Weihart – mergermarket, Sept 2019
Livac, a privately held Melbourne-based Australian developer of devices to support minimally invasive surgery (MIS), is actively seeking AUD 6m (USD 4m) from new investors to support US market entry, said CEO Anabela Correira.
The company, which has just completed all US Food and Drug Administration (FDA) regulatory requirements for its LiVac Retractor System, is keen to hear from investors in the US and Australia, including institutions, venture capital (VC) firms and strategics like medical device companies, Correira said. It has had interest from US VC firms, she added.
Livac is working with Melbourne-based investment bank Bletchley Park Capital for the raise and to tap US investors as well as with an unnamed advisor in the US that is assisting with introductions to investors, surgeons and distributors, Correira said.